Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer
Autor: | Yoshiki Ishii, Tomoe Funakoshi, Ryo Arai, Tomoko Okutomi, Fumito Ohmi, Akihiro Takemasa, Sayo Soda, Hiroko Morita |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Male Myeloid Lung Neoplasms medicine.medical_treatment Cell Separation 0302 clinical medicine Immunology and Allergy Cells Cultured Aged 80 and over education.field_of_study Antigen Presentation medicine.diagnostic_test Chemistry Immunosuppression hemic and immune systems General Medicine Middle Aged Flow Cytometry medicine.anatomical_structure 030220 oncology & carcinogenesis Female Research Article Boron Compounds lcsh:Immunologic diseases. Allergy Article Subject Immunology Antigen presentation Population chemical and pharmacologic phenomena Flow cytometry 03 medical and health sciences medicine Humans education Lung cancer Triglycerides Aged Neoplasm Staging Immunosuppression Therapy Blood Cells Cancer Lipid metabolism Dendritic Cells medicine.disease Lipid Metabolism 030104 developmental biology Cancer research Tumor Escape Lymphocyte Culture Test Mixed lcsh:RC581-607 |
Zdroj: | Journal of Immunology Research, Vol 2018 (2018) Journal of Immunology Research |
ISSN: | 2314-7156 2314-8861 |
Popis: | We studied the subsets of peripheral blood dendritic cells (DCs) and lipid accumulation in DCs to investigate the involvement of DCs in the decreased anticancer immunity of advanced lung cancer patients. We analyzed the population of DC subsets in peripheral blood using flow cytometry. We then determined lipid accumulation in the DCs using BODIPY 650/665, a fluorophore with an affinity for lipids. Compared with healthy controls, the number of DCs in the peripheral blood of treatment-naive cancer patients was significantly reduced. In patients with stage III + IV disease, the numbers of myeloid DCs (mDCs) and plasmacytoid DCs were also significantly reduced. Lipid accumulation in DCs evaluated based on the fluorescence intensity of BODIPY 650/665 was significantly higher in stage III + IV lung cancer patients than in the controls. In the subset analysis, the fluorescence was highest for mDCs. The intracellularly accumulated lipids were identified as triglycerides. A decreased mixed leukocyte reaction was observed in the mDCs from lung cancer patients compared with those from controls. Taken together, the results show that lung cancer patients have a notably decreased number of peripheral blood DCs and their function as antigen-presenting cells is decreased due to their high intracellular lipid accumulation. Thereby, anticancer immunity is suppressed. |
Databáze: | OpenAIRE |
Externí odkaz: |